Name | 4-cyano-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carboxylic acid |
---|---|
Synonyms |
N-BOC-4-CYANOPIPERIDINE-4-CARBOXYLIC ACID
4-cyano-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester 1-tert-butoxycarbonyl-4-cyano-4-piperidinecarboxylic acid |
Molecular Formula | C12H18N2O4 |
---|---|
Molecular Weight | 254.28200 |
Exact Mass | 254.12700 |
PSA | 90.63000 |
LogP | 1.54978 |
HS Code | 2933399090 |
---|
~97% 495415-34-4 |
Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2008/75110 A1, 2008 ; Location in patent: Page/Page column 138-139 ; WO 2008/075110 A1 |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |